Navigation Links
Targeted HIV Testing An Effective Way to Screen HIV Patients

According to an analysis by David Holtgrave, PhD, an expert on HIV prevention at the Johns Hopkins Bloomberg School of Public Health, a targeted campaign of testing and counseling aimed at those who are at high risk for HIV would be more effective than the mass patient screening proposed by the Centers for Disease Control and Prevention (CDC).

Holtgraves study is the first to examine the cost-effectiveness of the CDCs testing plan and is published in the June 2007 edition of the journal PLoS Medicine. The CDC estimates that 25 percent of Americans with HIV do not know they are HIV positive. Because they are unaware, they do not seek treatment and are at greater risk of spreading HIV to others.

To identify more Americans with HIV, the CDC has recommended that doctors in the United States test all patients aged 13 to 64 for HIV at every health care visit, unless the patient opts out, or specifically declines to be tested. In order to meet the demands of more testing, doctors can forgo the HIV risk reduction counseling that usually accompanies HIV testing.

'While the CDCs recommended opt-out testing offers some public health benefit, the data shows there would be substantially more benefit from a more targeted program that includes rather than discards risk reduction counselingincluding more diagnosed infections and more transmissions prevented,' said Holtgrave, who is professor and chair of the Bloomberg Schools Department of Health, Behavior and Society.

Using standard methods of cost-effectiveness analysis, Holtgrave estimates that CDCs recommended opt-out testing program would cost $864 million. For the same cost, a program of targeted counseling and testing would diagnose 188,170 new HIV infections, compared with 56,940 that would be detected through CDCs testing plan, assuming 1 percent of the population tested is HIV positive.

Additionally, targeted counseling and testing would prevent an estimated 14
'"/>




Page: 1 2

Related medicine news :

1. Gel Offers A More Targeted Approach
2. New Vaccine Targeted At Effective Treatment Against Tuberculosis
3. Doctors, Pharma Companies Targeted By CBI Raids
4. Treatment Resistant Tumors Can Be Targeted Better Using Botox
5. KFC Targeted in Lawsuit
6. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
7. Now, Silica Nanobubbles for Targeted Drug Delivery
8. Targeted Compound Helps Recurrent Prostate Cancer Patients
9. Tumors Targeted Naturally
10. New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs
11. Nanocomposite Labeled Cancer Cells Targeted and Destroyed by Using Lasers
Post Your Comments:
(Date:12/1/2008)...c. 1 Accuray Incorporate... of radiosurgery, announced today,that Fox Chase ...rKnife(R),Robotic Radiosurgery System. The CyberK...installed in Pennsylvania, and will be housed in a...ion in Buckingham, Pa. , Established in 190...
(Date:12/1/2008)...swire-FirstCall/ -- Affiliated Computer Services,...market with innovative solutions,designed to help... service.,With the expiration of an agreement tha... ACS can now offer its proven business process and...As the U.S. faces economic uncertainty, ACS will b...
(Date:12/1/2008)...ec. 1 Question. What would happen ...cle-building exercise? The,fitness world would ce...,membership fees would have to close. 2. Phony ex...existent. 3. We would never have to spend another ...ndustry,s take-home pay is now estimated at 35 bil...
(Date:12/1/2008)... Dr. Brian Snyder, a neurosurgeon at Neurologi...tate-of-the-art treatments in which he is speciall...used by neurological diseases. Neurological Surger... highly trained doctors in the New York area. Asid...tice also offers MRI testing, pain management, neu...
Breaking Medicine News(10 mins):Health News:Fox Chase Cancer Center Purchases CyberKnife System 2Health News:Fox Chase Cancer Center Purchases CyberKnife System 3Health News:Fox Chase Cancer Center Purchases CyberKnife System 4Health News:ACS Solutions for Federal Agencies: Meeting the Needs of a New Administration 2Health News:ACS Solutions for Federal Agencies: Meeting the Needs of a New Administration 3Health News:Push-Ups: 'It's Horizontal Jogging' 2Health News:Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor 2Health News:Novel Techniques Offers New Freedom to Patients with Parkinson's Disease, Epilepsy, Dystonia, and Tremor 3
...distiller's grains can be fed in a steam-flaked co... researchers//. The two four-month cattle finish...ed by Dr. Mike Brown, a Texas Agricultural Experim...st Texas A&M University associate professor, and D...
...ove an abbreviated new drug application (ANDA) for...ons of safety or efficacy// , the agency had to de...oving any generic version. The investigation fou...ues, and the FDA has announced that it can approve...
...n Wednesday rejected to consider Delhi government'...sions from three years to three-and-a-half years//...and Justice Sanjeev Khanna referred the matter to ...en set up to look into the aspect of admission pro...
...onal autism study has grim facts to state. The stu...between 6 and 12 have autism// and that it also ta...velopmental disorder. In addition, around 125,000...tism indicted by impaired communication problems, ...
Other Medicine News:Health News:Wet Distiller's Grains Could Play a Role in Cattle Diets 2Health News:Wet Distiller's Grains Could Play a Role in Cattle Diets 3
(Date:11/25/2008)... Nov. 25 Poniard,Pharma...ical company focused on,innovative oncology thera...trategic alternatives for its preclinical research...its resources on the clinical development of picop... the initial commercialization of,picoplatin in t...
(Date:11/25/2008)...nical Trial to Assess Survival of Patients Receivi...sectable Hepatocellular Carcinoma , , BELLE... Oncology, Inc. (LSO) today announced the completi...l of Light Infusion Therapy(TM) (Litx(TM)) as a tr...(HCC), also known as hepatoma or primary liver can...
(Date:11/24/2008)...Japan, Nov. 24 Takeda Pharmaceutic..., Takeda Global Research & Development Center,...visory Committee of the U.S. Food and Drug Adminis...uxostat for the treatment of hyperuricemia in pat...of approval, with one panel member abstaining. The...
(Date:11/24/2008)...RNewswire-FirstCall/ -- Leaders of Schering-Plough...te for investors on the company,s research pipelin...at includes 46 new entities in clinical trials or ...ies. , , "Research and development is addin...ntinue our transformation," said Fred Hassan, chai...
Breaking Medicine Technology:Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 2Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 3Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 4Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects 5Dr Gail Golab Head of AVMA Animal Welfare Division Becomes First U S Veterinarian Credentialed in Animal Welfare 26944 1Dr Gail Golab Head of AVMA Animal Welfare Division Becomes First U S Veterinarian Credentialed in Animal Welfare 26944 2SCAN Health Plan Arizona Announces Its 2009 MAPD Benefits for Maricopa County 26942 1SCAN Health Plan Arizona Announces Its 2009 MAPD Benefits for Maricopa County 26942 2Tennessee Introduces Long Term Care Partnership Insurance Policies and Producer Training Requirement 26940 1Tennessee Introduces Long Term Care Partnership Insurance Policies and Producer Training Requirement 26940 2Physician to Implant the CATANIA 28TM 29 Coronary Stent System With Polyzene 28R 29 F to Treat Chronic Total Occlusion During Live Case at the Paris C 8029 1Physician to Implant the CATANIA 28TM 29 Coronary Stent System With Polyzene 28R 29 F to Treat Chronic Total Occlusion During Live Case at the Paris C 8029 2Physician to Implant the CATANIA 28TM 29 Coronary Stent System With Polyzene 28R 29 F to Treat Chronic Total Occlusion During Live Case at the Paris C 8029 3
...lammation After,Menopause; Weight-Loss Surgery Imp...ce, ALEXANDRIA, Va., March 28, 2007 /PRNewswire/ -...to develop Parkinson,s disease as,they age, though...ink between the two diseases, according to a new s...s Care. , The study, by researchers in Finland, is...
...ges of nifedipine,GITS therapy , , ,LEVERKUSEN, ...shed articles in the Journal of Clinical Epidemiol...ong-acting calcium channel,blocker (CCB) nifedipin...nd its blood pressure lowing effect. A first,publi...demiology,2007; first published online) demonstrat...
Other Medicine Technology:Diabetes Linked to Higher Parkinson's Risk 2Diabetes Linked to Higher Parkinson's Risk 3Diabetes Linked to Higher Parkinson's Risk 4Calcium Channel Blocker Adalat GITS Offer Additional Benefits 2Calcium Channel Blocker Adalat GITS Offer Additional Benefits 3
0.2ml Gradient Block MBSR. Robot compatible block ejection mechanism. Stackable. (96 well block - holds 1 plate 0.2ml x 96 well plate)
...rmal Cycler (PxE) is a licensed 96 well PCR machin...or value for money thermal cycling. It is built o...nce in manufacturing and retains a high level of a...her products in the range. The combination of rob...
Custom programming of 3 hot blocks and 1 cold block, 30% reduction in cycling time, Unmatched well-to-well uniformity, No gradient feature
Advanced Design With Exceptional Performance The sleek lines and inviting user interface might be the first things you notice, but the MyCycler is designed for performance. With benchspace and time a
Medicine Products: